COMMUNIQUÉS West-GlobeNewswire

Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer
14/06/2018
NORTHVALE, N.J., June 14, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP) today announced that a member of its Board of Directors, Eugene Pfeifer, passed away on Sunday, June [...]
Pluristem to Open Weekly Market Trading at TASE Following Positive Study Results
14/06/2018
HAIFA, Israel, June 14, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, is delighted to announce that it has been invited by [...]
Hydropothecary receives its first phase of licensing for 250,000 sq. ft. greenhouse expansion
14/06/2018
GATINEAU, Quebec, June 14, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSXV:THCX) (“Hydropothecary” or “The Company”) is pleased to announce that the first two zones of its 250,000 sq. ft. greenhouse [...]
Hydropothecary reçoit un permis pour les deux premières zones de son expansion de 250 000 pi2
14/06/2018
GATINEAU, Québec, 14 juin 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSXV:THCX) (« Hydropothecary » ou « la Société ») a le plaisir d’annoncer que la première phase de l’expansion de 250 000 pieds carrés de ses [...]
Nightstar Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for NSR-REP1 in Choroideremia
14/06/2018
First gene therapy RMAT designation for an inherited retinal disease STAR Phase 3 registrational trial ongoing and FDA interactions planned RMAT designation enables closer and more frequent multidisciplinary interaction [...]
Achillion to Present at the 2018 JMP Securities Life Sciences Conference
14/06/2018
NEW HAVEN, Conn., June 14, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that Joseph Truitt, President and Chief Executive Officer of Achillion, will present at the 2018 JMP [...]
RavenQuest Announces Intent to Purchase Majority Stake in Elephant Extracts
14/06/2018
VANCOUVER, British Columbia, June 14, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (the “ Company ” or “ RavenQuest ”) is pleased to announce that it has entered into a letter of intent with 1090252 B.C. [...]
PotNetwork Holdings, Inc. Senior Advisor Bruce Barren Returns to the Nationally Syndicated “Mick Bazsuly Show” to Present Corporate Update Thursday, June 14, at 12:00 PM
14/06/2018
Senior Advisor Bruce Barren Set to Discuss Recently Expanded Product lines, Recent Record Online Revenues, Sales Performance and Other Milestones FT LAUDERDALE, Fla., June 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE [...]
GN Audio increases financial guidance for 2018
14/06/2018
GN Audio increases the financial guidance for 2018: The organic revenue growth guidance is upgraded from “around 9%” to “up to 15%” Based on the upgraded organic growth guidance, the EBITA margin is upgraded from “more [...]
The improved decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018.
14/06/2018
Latvia, 2018-06-14 08:24 CEST (GLOBE NEWSWIRE) -- The improved decisions of Latvijas Juras medicinas centrs JSC Annual Shareholders’ Meeting on June, 12, 2018. Information about Ex-date is added to p.2. of the decision [...]
Fermion's new plant operational in Hanko - nearly 100% of production is exported
14/06/2018
Orion Corporation Press release 14 June 2018 at 9.00 a.m. Fermion's new plant operational in Hanko - nearly 100% of production is exported Fermion Oy, which manufactures active pharmaceutical ingredients (APIs) for the [...]
Shire plc : Rule 2.9 Announcement
14/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 14 June 2018 Shire [...]
Motif Bio Submits NDA for Iclaprim
14/06/2018
NEW YORK, June 14, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced the completion of its rolling [...]
Bone Therapeutics SA announces results of Annual General Meeting
14/06/2018
Press release Bone Therapeutics announces results of Annual General Meeting Company reshapes and strengthens its Board of Directors with focus on improving governance and diversity Additional Extraordinary Shareholders [...]
Bone Therapeutics SA annonce les résultats de l'Assemblée Générale Ordinaire du 13 juin 2018
14/06/2018
Communiqué de presse Bone Therapeutics annonce les résultats de l'Assemblée Générale Ordinaire du 13 juin 2018 Renforcement de la gouvernance et de la diversité au sein du Conseil d'administration Organisation d'une [...]
argenx announces data from Phase 1 study of efgartigimod (ARGX-113) subcutaneous formulation demonstrating comparable characteristics to intravenous formulation
14/06/2018
- Subcutaneous formulation offers potential for increased patient convenience and acceptance - June 14, 2018 Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology [...]
Agility Health Announces Management Cease Trade Order Update
14/06/2018
GRAND RAPIDS, Mich., June 13, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“ Agility Health ” or the “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services in Canada, is [...]
Innovate Biopharmaceuticals Announces Appointment of Saira Ramasastry to Board of Directors and Resignation of Anna Kazanchyan, M.D.
14/06/2018
RALEIGH, N.C., June 13, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]
New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data
13/06/2018
NanoFlu TM Phase 1/2 trial data published in a peer-reviewed letter to the editor in The New England Journal of Medicine NanoFlu demonstrates significantly improved immune responses against a panel of homologous and [...]

Pages